Search
for
Sort by
Research 121–150 of 1000+
- Farmácia Boa Hora - Porto
- Effects of High-dose Radioactive Iodine Therapy on Hormonal Profiles and Sperm Quality in Thyroidectomy Patients
- Is dehydroepiandrosterone a hormone?
- Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed – A Review for Primary Care
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Period problems: disorders of menstruation in adolescents
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Common urologic diseases in older men and their treatment: how they impact fertility
- Influence of The Anabolic Steroid Usage on The Physical Health: A Review
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Penis Endocrinology
- LO-010 Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus
- Correlation between MRI findings of pituitary gland and prolactin level among hyperprolactinemia adult female Saudi patients in rural areas: A retrospective multicentric study
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- Adverse effects with finasteride 5 mg/day for patterned hair loss in premenopausal women
- Metabolic Aspects of Polycystic Ovary Syndrome
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Female pattern hair loss—An update
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland
- Skin disease related to metabolic syndrome in women
- Mitochondria Dysfunction and Inflammation in Traumatic Brain Injury: Androgens to the Battlefront
- Examining the association of menarche and correlates in a rural polycystic ovary syndrome population: A cross-sectional study
- Impact of estrogens in males and androgens in females
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome